
Process Engineer, Manufacturing Sciences & Technology, Cell Therapy
AstraZeneca
Summary
Support on-the-floor / hands-on technical support, develop technical instructions, procedures, and operator training content, perform data analysis and process performance trending, support deviation investigations, drive implementation of CAPAs and continuous improvement through change controls, and contribute to validation and regulatory deliverables. Responsibilities are exercised through technology transfer, clinical manufacturing, site readiness, process validation/PPQ, commercial manufacture readiness, and product lifecycle management activities.
Job description
Key Responsibilities
- Provide day-to-day technical support for cell therapy manufacturing, including on-the-floor support for critical campaigns (including occasional off-shift support where required)
- Represent Site MS&T function at site operational tier meetings, providing collaborative inputs that drive site activities
- Lead or co-lead technical investigations for deviations and process excursions, perform root cause analysis, develop and implement CAPAs with appropriate data
- Maintain manufacturing data tracking system and control charts, perform trend analyses, identify signals, and drive timely signal-to-action with clear documentation and cross-functional alignment
- Conduct batch record review, deviation assessment, and data trending to ensure robustness of cell therapy manufacturing processes
- Identify, justify, and implement continuous improvements by shepherding changes through cross-functional change controls with appropriate risk assessments and comparability
- Assess impact of raw material changes, and contribute to second-source strategies
- Author and revise batch records, SOPs, and technical reports; protocols, manufacturing summary reports; ensure adherence to cGMP/ATMP requirements and data integrity principles (ALCOA+)
- Deliver operator training on critical process steps or process changes; contribute to lessons-learned, playbooks, and best practices across sites
- Support drafting of CMC sections (Module 3) or response to agency questions, support health authority and internal audits/inspections
- Draft and review risk assessments
- Contribute to technology transfer packages (process descriptions, URS inputs, BOMs, risk assessments), implement process changes, coordinate execution of engineering runs and comparability/bridging studies, author technical reports
- Translate process characterization outputs from development into manufacturing controls, and draft sections of PPQ protocols/reports
- Provide on-the-floor technical support during scale-up, engineering runs, PPQ batches, and commercial manufacturing campaigns (including off-shift support when required)
- Serve as primary interface between site Manufacturing, site Quality, site Supply Chain, and global functions of Process Development and CMC regulatory
- Support lifecycle management for cell therapy processes, including continuous improvement initiatives and post-approval changes
Required Qualifications
M.S. in Chemical Engineering, Biochemical Engineering, Biotechnology, or related field with 1+ years of industry experience; OR B.S. with 3+ years of hands-on industry experience.
- Strong technical and hands-on expertise in key cell therapy unit operations and common cell therapy processing equipment
- Demonstrated experience working in GMP environments, including batch record execution or review, deviations, and investigations
- Proficiency with statistical analysis (including univariate, multi-variate analysis, control charts)
- Demonstrated ability in accurate and thorough technical writing, paired with clear and concise verbal communication
- Strong data analysis and problem-solving skills
- Excellent cross-functional communication and collaboration
- Ability to translate complex data into clear decisions and regulatory-ready narratives
- Excellent problem solving, cross-functional partnership, and communication under time-sensitive conditions
Preferred Qualifications
- Experience with late-stage clinical manufacturing support of cell therapy products
- Experience with process validation and commercial readiness of cell therapy products
Work Environment
- On-site in Tarzana, CA
- Ability to travel ~10% to other manufacturing facilities
- On-call rotation during engineering/PPQ/critical campaigns
Requirements
- M.S. in Chemical Engineering, Biochemical Engineering, Biotechnology, or related field with 1+ years of industry experience; OR B.S. with 3+ years of hands-on industry experience
- Strong technical and hands-on expertise in key cell therapy unit operations and common cell therapy processing equipment
- Demonstrated experience working in GMP environments, including batch record execution or review, deviations, and investigations
- Proficiency with statistical analysis (including univariate, multi-variate analysis, control charts)
- Demonstrated ability in accurate and thorough technical writing, paired with clear and concise verbal communication
- Strong data analysis and problem-solving skills
- Excellent cross-functional communication and collaboration
- Ability to translate complex data into clear decisions and regulatory-ready narratives
- Excellent problem solving, cross-functional partnership, and communication under time-sensitive conditions
Benefits
- 401(k) Retirement Programs
- Paid Time Off
- Vacation
- Holiday Leave
- Health Insurance
- Dental Coverage
- Vision Coverage
- Short-Term Incentive Bonuses
- Equity-Based Awards
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.